Description:

Study ID: 100527 Clinical Study ID: B2E100527 Study Title: A randomised, double blind, placebo controlled, parellel group study to examine the efficacy, safety, tolerability and systemic pharmacokinetic profile of repeated inhaled doses of GSK159797 Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: Milveterol Study Indication: Pulmonary Disease, Chronic Obstructive

Keywords:
Versions (1) ▾
  1. 6/18/17
Uploaded on:

June 18, 2017

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Screening - GSK Milveterol COPD 100527

Screening - GSK Milveterol COPD 100527

Inclusion/Exclusion criteria
Demography
dd.mm.yyyy
dd.mm.yyyy
cm
kg
Duration of Asthma
Vital Signs
dd.mm.yyyy
hh:mm
mmHg
mmHg
beats/min
12-Lead Electrocardiogram
dd.mm.yyyy
hh:mm
beats/min
msec
msec
msec
msec
FEV1 / Reversibility Testing
dd.mm.yyyy
hh:mm
%
%
Hematology Data
dd.mm.yyyy
hh:mm
Clinical Chemistry Data
dd.mm.yyyy
hh:mm
Urinalysis
dd.mm.yyyy
hh:mm